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Abstract
Background: Traumatic experiences and, more specifically, posttraumatic stress disorder (PTSD) are highly prevalent
among substance use disorder (SUD) patients. This comorbidity is associated with worse treatment outcomes in
substance use treatment programs and more crisis interventions. International guidelines advise an integrated
approach to the treatment of trauma related problems and SUD. Seeking Safety is an integrated treatment program
that was developed in the United States. The aim of the current study is to test the efficacy of this program in the
Netherlands in an outpatient SUD population.
Methods/Design: A randomized controlled trial (RCT) will be used to test the efficacy of Seeking Safety compared
to Cognitive Behavioral Therapy (CBT) in a population of SUD outpatients. Each treatment will consist of 12 group
sessions. The primary outcome measure will be substance use severity. Secondary outcome measures are PTSD and
trauma symptoms, coping skills, functioning, and cognitions. Questionnaires will be administered at the start of
treatment, at the end of treatment (three months after the start of treatment) and at follow-up (six months after
the start of treatment).
Discussion: This study protocol presents a RCT in which the efficacy of an integrated treatment for comorbid PTSD
and SUD, Seeking Safety, is evaluated in a SUD outpatient population compared to CBT. It is expected that the
intervention group will show significantly more improvement in substance use severity compared to the control
group at end-of-treatment and at follow-up. Furthermore, a lower drop-out rate is expected for the intervention
group. If the intervention proves to be effective, it can be implemented. A cost-effectiveness analysis will be
conducted to evaluate the two treatments.
Trial registration: The protocol for this study is registered with the Netherlands Trial Register with number
NTR3084 and approved by the local medical ethical committee (METC\11270.haa).
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Background
A history of traumatic experiences is very common among
substance use disorder (SUD) patients, with estimates ran-
ging from 55%–99% [1,2]. Furthermore, high rates of
posttraumatic stress disorder (PTSD) have been found
among SUD patients. The rate of drug and/or alcohol
dependence in veteran populations varies from 40% to
75% [3,4]. In civilian populations with lifetime PTSD
prevalence of SUD’s ranges from 22% to 43%, compared
with 2% to 15% in persons without PTSD [5]. Among
SUD patients the rate of PTSD varies between 11%–60%
for current PTSD and 33%–75% for lifetime PTSD [2,6,7].
These high rates of comorbidity suggest that PTSD
and SUD are functionally related. Several pathways have
been described in which these two disorders relate to
one another, such as the “self-medication hypothesis” in
which PTSD precedes SUD [8]. When SUD precedes
PTSD, a likely explanation is that substance users often
risk hazardous situations to sustain their habit, and
therefore experience high levels of physical and psycho-
logical trauma. This in turn, increases the chance of de-
veloping a PTSD [9]. Finally, there is accumulating
evidence that both disorders share neurobiological sys-
tems, so that continued substance use may increase an
individual’s susceptibility to developing PTSD following
a trauma and, vice versa, that PTSD increases the
vulnerability for developing SUD [10].
The association between SUD and PTSD is clinically
significant, as well as the association with traumatic expe-
riences in general, because trauma exposure and related
PTSD symptoms have the potential to affect SUD treat-
ment. These symptoms include re-experiencing the
trauma, avoidance, and increased anxiety or hyperarousal.
In addition to related symptoms of depression, they inter-
fere with patients’ abilities to adhere to and benefit from
substance abuse treatment [11,12]. International guide-
lines advise to integrate the treatment of SUD and trauma
related disorders such as PTSD [13-15].
Seeking Safety is a therapy that was developed in the
United States as an integrated treatment for PTSD and
SUD [16]. It has also been found a feasible treatment for
patients who are subthreshold on these disorders or who
have just one or just the other disorder. The treatment is
cognitive-behavioral, as well as addressing interpersonal
and case management domains. It is present-focused and
designed to help patients learn coping skills to attain safety
from trauma/PTSD and substance abuse. Seeking Safety
has had over 20 published studies (see [17], for a compre-
hensive review). It has shown to reduce substance use and
PTSD symptom severity in comparison with a control
group in female patients [18], female adolescents [19],
incarcerated women with SUD and PTSD [20] and in
veterans in outpatient treatment [21], for example. Various
quasi-experimental and non-controlled studies show
positive outcomes for Seeking Safety [22-31]. The treat-
ment has shown positive results in the United States and
is the only model for PTSD/SUD thus far to impact both
PTSD and SUD [17]. The French translation of Seeking
Safety has had positive findings and satisfaction in a
Canadian study [32]. The Dutch translation, however, has
never been studied. Cultural differences in expectancies
from health care providers, differences in communicating
and general views may cause differences in adherence and
efficacy.
Aims
The aim of this study is to test the efficacy of Seeking
Safety versus standard CBT in a Dutch sample of out-
patient SUD patients who have experienced at least one
traumatic event. As the population under study consists
of patients in treatment for substance use, the primary
outcome measure is substance use severity. Secondary
outcome measures are PTSD and trauma symptoms,
coping skills, functioning, and cognitions. We will also
assess drop-out and satisfaction.
A second aim of the study is to perform a cost-
effectiveness analysis to compare the two treatments.
Methods
Study design
For this study a randomized controlled design is used.
Semi-structured interviews and self-report question-
naires will be used to measure change over time on vari-
ables at three time points: at the start of the treatment
(t = 0), at end of the treatment (t = 1) and three months
after the end of treatment (follow-up, t = 2). These
points in time are chosen to conform to standard evalu-
ation procedures within our facility. Routine outcome
monitoring is conducted at completion of treatment for
the outpatients or at three months after the start of
treatment. The administration of questionnaires for the
study will be synchronized with this monitoring. Both
Seeking Safety and CBT will consist of weekly group ses-
sions of 1 3/4 hours for 12 weeks (12 sessions total).
This design keeps dosage equivalent across the treat-
ment conditions, and has been used successfully in a
prior recent RCT of Seeking Safety [21]. Both Seeking
Safety and CBT will be offered in closed-group format, as
this is the standard in the control condition. Participants
will not be financially rewarded for their participation.
The results of the study will be presented following the
CONSORT guidelines [33].
Participants
Recruitment
All patients that enter group-based weekly therapy are
asked to participate during intake. They will receive a
letter explaining the purpose of the study, what they can
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expect and the requirements to participate, and an in-
formed consent. They are asked to read the information
carefully and decide on participating within two days.
Inclusion criteria
Eligible participants for this study are both male and fe-
male patients that enter group-based outpatient substance
use treatment. They have to be 18 years of age or older
and sufficiently fluent in the Dutch language. In this study
we will include all patients who have experienced a trau-
matic event and have trauma-related symptoms. These are
assessed by asking the patients whether or not they have
experienced a traumatic event, and have a score of at least
40 on the Self-report Inventory for PTSD (SRIP). Further-
more, patients meet current DSM-IV criteria for substance
dependence or abuse and have active substance use in the
previous 30 days.
Exclusion criteria
Patients will be excluded at intake if they have current
uncontrolled psychotic or severe bipolar disorder; or
serious danger to self or others (defined as stated intent
to commit suicide or an act of violence, with clear intent
and plan). These will be determined by a psychologist or
a psychiatrist.
Randomization
Randomization will be at patient level. The participants
will be randomly appointed to either the control group
or the experimental group. The care-takers are blind for
this randomization. Envelopes will be distributed to the
treatment facility and these contain the questionnaires
that will be administered at t = 0. After completing the
questionnaires patients will be randomized based on a
predefined randomization schedule. Randomization will
be performed in blocks of 4 and 8 (in random order).
The research assistants that administer the question-
naires for t = 1 and t = 2 will be kept blind for this
randomization.
Sample size calculation
The sample size for this study is calculated using a
significance level of 95% (p < 0.05), a power of 80% and
the same number of patients in the intervention and
control group (ratio = 1).
Primary outcome variable is substance use severity as
measured with the EuropASI. In recent studies,
conducted within the same institution [34] but with a
population of inpatients, a mean baseline score of 5.2
was found for the alcohol domain and 4.0 for the drugs
domain. We expect the mean baseline scores for the out-
patients to be somewhat lower, however not considerably.
For comparison of baseline scores on the EuropASI, see
[22,23]. For practical reasons we are using the mean of
both domains (alcohol and drugs) for the sample size cal-
culation. Thus, the mean score for substance use severity
will be somewhat lower than (5.2 + 4.0)/2 = 4.6 with a
standard deviation of 2.7. For this sample size calculation
we will use a baseline score of 4.0 with the same standard
deviation. We expect the substance use severity to im-
prove with 60% [23] to 1.6 (SD = 2.0) at end-of-treatment
for the intervention group and 2.8 (SD = 2.0) for the
control group. We used PS – Power and Sample Size
Calculation to calculate the sample size, which resulted in
a sample size of 45 patients in each group. Drop-out rates
for this treatment are available for the past years from a
management information system and are estimated
around 20%. This drop-out rate may seem low compared
to the numbers that are known from previous studies in
SUD patients. However, we will use this percentage to
calculate the number of patients that are needed, but will
perform an analysis on drop-out halfway through the
study. When the drop-out rates turn out to be higher than
expected, an amendment will be proposed to the medical
ethical committee to continue including patients for an
extended period of time. Because of the calculated drop-
out rate, an extra 9 participants will be included in both
the intervention and the control group, yielding a total of
108 participants for the randomized controlled trial. Based
on treatment entry numbers from previous years, approxi-
mately two years will be needed to include all patients.
Furthermore, this number of patients seems plausible
considering sample sizes in previous studies that show
similarity in design [21,22].
Ethics
The study was approved by the local medical ethical
committee (METC\11270.haa).
Treatment program
Intervention
Patients will be randomized to either Seeking Safety or
to standard CBT. Seeking Safety was originally designed
as an integrated model for patients that have both PTSD
or trauma-related symptoms and SUD. The treatment
manual has recently been translated into Dutch [35].
Seeking Safety consists of 25 structured topics, which
can be conducted in group or individual modality. In
this study, it will be conducted in group modality.
Topics are evenly divided among cognitive, behavioral
and interpersonal coping skills, with a goal of helping
patients attain safety in their lives. ‘Safety’ is defined as
reduction in substance use and destructive behavior,
establishment of a network of supportive people and self-
protection from dangers associated with the disorders.
There will be one Seeking Safety topic per session for
the duration of three months, making it possible for
patients to receive 12 topics. The topics to be used are:
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Safety; PTSD-Taking Back Your Power; When Substances
Control You; Grounding; Healing from Anger; Honesty;
Taking Good Care of Yourself; Compassion; Red and
Green Flags; Asking for Help; Creating Meaning; and Life
Choices.
Patients that attend a minimum of 7 sessions will be
considered “minimum dose completers” [36]. Every ses-
sion is conducted according to a fixed structure, starting
with a check-in to find out how each patient is doing
and both strengths and problems in coping since the last
session. Second, a quotation is discussed followed by a
discussion of the hand-outs in which the topic of the
session is related to the patients’ life. This is also the
place where coping skills are shared and discussed. Each
session ends with a check-out where patients are
encouraged to share one thing they have learned during
the session and to formulate a commitment (homework)
for the next session. The sessions will be facilitated by
one therapist or social worker. The therapists and social
workers all received a two-day training in Seeking Safety.
Furthermore, all sessions will be videotaped and a
random sample of 20% will be selected for review. Thus,
quality and adherence will be monitored and ongoing
supervision will be provided.
Comparison condition
Cognitive Behavioral Therapy (CBT) is an evidence-
based cognitive behavioral, manual-based model focused
on reducing substance use. It includes relapse preven-
tion and motivational interviewing in which positive
reinforcement and enhancing self-efficacy among others,
are used to attain behavioral change in the patient [37].
CBT is offered once a week for a period of three months
in a closed group.
Data collection
Patients in both treatment conditions will be assessed
identically: at the start of treatment (baseline), at the end
of treatment (after three months) and at follow up (six
months after start of treatment). Patients will be
assessed by research assistants at these time points.
Under their supervision patients will fill out most of the
questionnaires in an online environment in which the
data is linked to their electronic patient file.
Instruments and outcome
The primary outcome in this study is substance use
severity at end of treatment as measured with the
EuropASI. This measure will provide a composite score
for alcohol and drugs which incorporates the number of
days of use in the previous 30 days, amount of money
spent on drugs or alcohol, perceived problems and
burden of problems associated with substance use. The
composite score for alcohol use severity will be used as
the primary outcome measure for patients with alcohol
use disorder and the composite score for drug use sever-
ity will be used for patients with substance use disorder
according to the DSM-IV. Secondary outcome measures
are the other measures listed below.
European addition severity index (EuropASI)
The EuropASI is the European adaptation of the fifth
edition of the addiction severity index [38]. It is a semi-
structured interview that gives a multidimensional profile
of the substance-dependent individual and the severity
of the addiction. It covers seven main problem areas
(medical, employment, alcohol, drug, legal, psychiatric,
and family and social) that are most commonly affected
by substance abuse. Scoring is based on two indices for
each problem area: firstly, the interviewer’s severity rating,
in which the interviewer indicates the severity of the pa-
tient’s problems and his or her present need for additional
treatment on a 9-point scale. Secondly, a composite score
(range 0 - 1), an arithmetically based indicator of current
(30 day) problem severity, is obtained. Composite scores
for the EuropASI are computed with a strategy similar to
the one used in the ASI [39].
Obsessive compulsive drinking scale (OCDS)
The OCDS is a quick and reliable self-rating instrument
that provides a score that measures cognitive aspects of
craving of alcohol or drugs during the past seven days
[40]. The short version of the scale [41] that is used in
the current study consists of 5 items which can be
scored on a 0-4 scale, where a higher score indicates
higher obsessions and compulsions regarding drugs or
alcohol.
Self report inventory PTSD (SRIP)
The SRIP is a self-report measure of PTSD [42]. The
duration of this measure is five minutes, which makes it
very time-efficient. The SRIP contains 22 items, based
on the DSM-IV-TR criteria for PTSD. The items are
scored on a 4-point Likert scale, varying from 1 ‘not at
all’ to 4 ‘often’, and indicates the intensity of the PTSD-
symptoms in the past month. A total-score of 52 or
higher indicates a PTSD-diagnosis. The SRIP uses the
three subscales described in de DSM-IV-TR criteria:
‘Intrusion’, ‘Avoidance’, and ‘Hyper arousal’. Besides this,
the 22 items are subdivided in four factors: ‘Emotional
numbing’, ‘Avoidance’, ‘Intrusion’, and ‘Sleeping problems’.
The test does not contain trauma-specific items, there-
fore the SRIP is suitable for any population. Research
provides evidence for a high reliability of this measure.
Hovens [43] found, with the Clinician Administered
PTSD Scale (CAPS) [44] as criterion, an internal consist-
ence reliability of the total score between .90 and .94.
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Trauma symptom checklist (TSC-33)
The TSC-33 is a research measure that evaluates symptom-
atology in adults associated with childhood or adult trau-
matic experiences. It measures aspects of posttraumatic
stress and other symptom clusters found in some trau-
matized individuals. It does not measure all 17 criteria
of PTSD, and should not be used as a complete measure
of that construct [45]. It is included in the current study
to measure the aspects of psychological effects of trau-
matic experiences in addition to the standard DSM-IV
criteria of PTSD.
Utrecht coping list (UCL)
The UCL [46] is a self-report instrument to measure the
way people deal with problems or stressful situations.
The questionnaire consists of 47 items divided into 7
subscales measuring seven different coping strategies:
1. ‘Active problem solving’, 2. ‘Palliative responses’,
3. ‘Avoidance and passive expectancy’, 4. ‘Seeking social
support’, 5. ‘Depressive reaction pattern’, 6. ‘Expressing
emotions’ and 7. ‘Comforting cognitions’. Each item
can be answered with ‘seldom or never’, ‘sometimes’,
‘often’ and ‘very often’. A total score is obtained by
adding the scores of all items together.
It is important to note, that although Seeking Safety
emphasizes coping skills, we do not expect the scores of
all patients to improve on every subscale of the UCL.
Some of the ideas behind Seeking Safety are actually
aimed at helping patients to avoid certain situations or
feelings. This is not considered to be good or bad. The
purpose of this study is to explore changes in coping
styles and relate these changes to Seeking Safety.
EuroQol-5D (EQ-5D)
For the overall quantification of health status as a single
index we will use the standard EQ-5D classification sys-
tem developed by the EuroQol Group [47]. The EQ-5D
is one of the three widely used multi-attribute systems
available to determine health state preferences (utilities).
The EQ-5D classification describes health status
according to five attributes (five questions): mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression. Each attribute has three levels, i.e., ‘no prob-
lems’ (1), ‘some problems’ (2) and ‘severe problems’ (3).
Health state descriptions are constructed by taking one
level for each attribute (e.g., 11111 represents the highest
health status). Theoretically this set of attributes and the
levels of the EuroQol-5D instrument allow for 243 (35)
different health-status descriptions. Based on the de-
scriptive classification of the EQ-5D system a preference
index (utility) can be estimated that expresses the overall
preference of the classified health status. These utility
figures are required to calculate Quality-Adjusted Life
Years (QALYs) for the cost-utility analysis [48].
Sheehan disability scale (SDS)
The SDS [49] is a brief self-report measure that was
developed to assess functional impairment in three
inter-related domains: work/school, social and familiy
life. The patient rates the extent to which problems in
these areas are present on a 10 point visual analogue
scale and can thus be used to measure functioning.
Statistical analyses
All analyses will be executed using SPPS for Windows
version 18.0. Frequency tables will be provided for all
baseline, end of treatment and follow-up variables.
Descriptive statistics will include mean, median, inter-
quartile range, numbers and percentages of patients, as
appropriate. If applicable, 95% confidence intervals will
be given. To compare differences between groups (Seek-
ing Safety vs CBT) t-test or mann whitney U tests will
be used in case of continuous variables, as appropriate.
For categorical variables chi-squared tests will be used.
Repeated measures analyses (mixed models in SPSS) will
be used to test the differences between the treatment
conditions over time in severity of substance use prob-
lems as measured by the EuropASI severity score (pre,
post and follow-up). The data will be tested for normal-
ity and transformed as appropriate when the data are
skewed. Analyses will be based on the intent-to-treat
principle. Participants have to attend at least one session
to be considered part of this group. Differences regard-
ing gender will be analysed and when appropriate,
gender will be included in the analyses as a confounder
or effect modifier. Multiple Imputation will be used for
missing data. Effect sizes will be calculated to facilitate
comparison of improvement between the two groups.
Linear regression analyses will be used to determine the
predictors of change in substance use and trauma symp-
toms. Also, amount of prior psychiatric treatment will
be used in the analysis as a covariate.
Cost-effectiveness analysis
To make a comparison between the two treatments,
the cost of these treatments (total costs of staff and
materials) will be related to the benefits of the treat-
ment by performing a cost-effectiveness analysis. A
cost-effectiveness analysis requires a numerical esti-
mate of the magnitude of the effects of an intervention
on health outcomes. The primary outcome measure of
this study will be used for this purpose. Cost will be di-
vided by effects to calculate the cost-effectiveness ratio
(C/E). The statistics of interest in the economic evaluation
of health care interventions is the incremental cost-
effectiveness ratio, which is defined as the difference in
cost between Seeking Safety and CBT. To quantify uncer-
tainty in the estimated incremental cost-effectiveness ratio,
confidence intervals will be calculated. In addition, a
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special variant of economic analysis is planned, i.e., cost-
utility analysis, to incorporate the preferences (utilities) of
the participants considering their own health status at the
start of treatment and after follow-up. Based on these
preferences combined with life expectancy figures, calcula-
tion of so-called QALYs is applicable. A general measure
to express the benefits of the two different treatment strat-
egies will be calculated by subtracting the number of
quality-adjusted life years computed after follow-up from
the number of QALYs computed at baseline. Subse-
quently, quality-adjusted life years can be combined with
the cost of each treatment strategy to arrive at the cost per
QALY gained [48,50].
Discussion
This study protocol presents the design of an RCT
evaluating the efficacy of the Seeking Safety treatment
program in the Netherlands. The goal of the treatment
is to reduce substance use and PTSD-related symptoms.
Recently Najavits and Hien have summarized the litera-
ture on Seeking Safety, which shows consistent improve-
ments when Seeking Safety is used, even among highly
complex and severe patients [17]. Therefore it can be
expected that an integrated treatment approach for
substance use and trauma-related problems can be very
effective. Although Seeking Safety has already shown
positive results and is considered to be the first choice
of evidence-based treatment for comorbid SUD and
PTSD, there are several reasons why this RCT should be
conducted.
Firstly, the studies from which the results have been
used as evidence for the efficacy of Seeking Safety, are
largely conducted in the United States. SUD populations
in the United States and Europe or the Netherlands are
very similar as general characteristics are concerned. How-
ever, communication styles differ between countries,
because of cultural differences. Also, the Netherlands are
known for its liberal policies and views towards several
issues, for example drugs. These differences could have
influence on the way patients perceive and adhere to Seek-
ing Safety. The treatment uses a book with handouts for
patients and guidance for therapists. This book and its
handouts have been translated into Dutch in 2010 [35],
however, it is important to test the efficacy of the Dutch
version for reasons mentioned above. A natural choice for
a comparision condition is CBT, which is considered the
gold-standard treatment for SUD alone.
Secondly, the majority of studies focused on female
populations of SUD patients. While this group in par-
ticular may benefit from Seeking Safety, studies on male
subpopulations have emerged over the last few years
[51]. In general, there are approximately twice as many
male patients than female patients in substance use
treatment [52] and it is therefore interesting to see what
the effect of Seeking Safety is on a population where
men are the majority and Seeking Safety groups are
mixed-gender. The effect of gender in response to
PTSD-focused treatment has not yet been systematically
studied [13]. Therefore, in the current study gender will
be studied as a possible confounder or modifier of the
effect of Seeking Safety.
Thirdly, while previous studies on Seeking Safety have
mostly been focused on patients with PTSD, in this
study patients will also be included if they have experi-
enced a traumatic event and present with some PTSD
symptoms, but not necessary with full-blown PTSD.
That way, the possible benefits of this treatment will be
available for a substantial larger group of patients. A
possible limitation of this procedure is that self-reported
PTSD-related symptoms will be used to include patients
in the study. Because the sample will consist of SUD
patients, a proportion of the symptoms they report, may
be due to substance use or withdrawal (e.g. sleep problems,
difficulties concentrating). The symptoms of hyperarousal
could be independent of any traumatic experience. For the
purpose of this study, however, this is not a problem. There
may be instances where a patient is included in the study
while his symptoms are primarily related to substance use,
but we still expect this patients to benefit from Seeking
Safety in alleviating his symptoms.
The aim of this RCT is to test the efficacy of Seeking
Safety versus CBT in an outpatient population of SUD
patients. The design of the study is based on the fact
that both Seeking Safety and CBT are evidence-based
models, but CBT does not address trauma or PTSD. We
expect that a majority of the patients may benefit from a
treatment that focuses on both trauma and substance
use. If the intervention group is more successful in redu-
cing substance use and PTSD symptoms, it can be ar-
gued that Seeking Safety should be offered for patients
presenting with trauma issues.
If either treatment proves to be more effective, cost-
effectiveness must also be taken into account because
scarcity of resources is a permanent feature of mental
health care and substance use treatment in particular. It
is well documented that patients that experienced
trauma are in general higher users of services in the
health care system [53]. However, it is difficult to deter-
mine for each hospitalization or crisis whether or not
underlying PTSD is its direct cause, which makes eco-
nomic evaluations difficult. Domino et al. [54] attempted
to shed light on this subject by analyzing total service
costs of women with mental health and substance abuse
disorders who have experienced trauma. One group of
women was enrolled in an intervention condition, which
provided comprehensive, integrated and trauma-informed
services. The other women received care-as-usual. The
results showed that the intervention modestly improved
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clinical outcomes, especially drug use and trauma out-
comes, and that there were no differences in cost between
the intervention and the comparison condition. This pro-
vides support for the notion that integrated and trauma-
focused interventions can be effective treatments for SUD
patients with traumatic experiences, with no significant
extra cost.
Implications for practice
If Seeking Safety turns out to be an effective treatment
for the population under study, it could be implemented
broadly within the outpatient setting of addiction treat-
ment facilities. Cost-effectiveness analyses will be used
to inform policy makers about the possible advantages
of implementing Seeking Safety versus CBT.
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